Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Department of Gastroenterological Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Surg Today. 2021 Aug;51(8):1343-1351. doi: 10.1007/s00595-021-02257-x. Epub 2021 Mar 3.
Although decreased antithrombin-III (AT-III) is a risk factor for portal vein thrombosis (PVT) in patients with liver cirrhosis, the association between postoperative PVT and postoperative AT-III levels is unknown in patients undergoing hepatectomy.
Patients who underwent hepatectomy between 2015 and 2018 were retrospectively analyzed. Postoperative PVT was assessed on CT at days 6-9 after hepatectomy. One-to-one propensity score (PS) matching was used to match the baseline characteristics.
Of the 295 patients included in this analysis, 19 patients (6.4%) were diagnosed with postoperative PVT. The AT-III level on postoperative day (POD) 3 predicted postoperative PVT with a sensitivity/specificity of 74%/59% (AUC, 0.644; cut-off value, 60%; p = 0.032). Multivariate analysis revealed that AT-III levels ≤ 60% on POD3 (OR, 3.01; 95% CI 1.02-8.89; p = 0.046), cirrhosis (OR, 5.88; 95% CI 1.92-18.0; p = 0.002) and right-sided hepatectomy (OR, 4.16; 95% CI 1.45-11.9; p = 0.0079) were significant risk factors for postoperative PVT. After PS matching, 56 patients with and without AT-III supplementation were analyzed. The two groups had a similar incidence of PVT (p = 0.489).
Patients with AT-III levels ≤ 60% on POD3 should be carefully followed up regarding postoperative PVT. Our results did not support the efficacy of routine AT-III supplementation for the prophylaxis of postoperative PVT.
尽管抗凝血酶-III(AT-III)减少是肝硬化患者门静脉血栓形成(PVT)的危险因素,但肝切除术患者术后 PVT 与术后 AT-III 水平之间的关系尚不清楚。
回顾性分析了 2015 年至 2018 年间接受肝切除术的患者。在肝切除术后第 6-9 天行 CT 评估术后 PVT。采用 1:1 倾向评分(PS)匹配来匹配基线特征。
在本分析中,共有 295 例患者,其中 19 例(6.4%)诊断为术后 PVT。术后第 3 天的 AT-III 水平预测术后 PVT 的敏感性/特异性为 74%/59%(AUC,0.644;截断值,60%;p=0.032)。多变量分析显示,术后第 3 天 AT-III 水平≤60%(OR,3.01;95%CI,1.02-8.89;p=0.046)、肝硬化(OR,5.88;95%CI,1.92-18.0;p=0.002)和右半肝切除术(OR,4.16;95%CI,1.45-11.9;p=0.0079)是术后 PVT 的显著危险因素。在 PS 匹配后,分析了 56 例接受和未接受 AT-III 补充的患者。两组 PVT 发生率相似(p=0.489)。
术后第 3 天 AT-III 水平≤60%的患者应密切关注术后 PVT。我们的结果不支持常规 AT-III 补充用于预防术后 PVT。